Private Capital Management, LLC Harrow Health, Inc. Transaction History
Private Capital Management, LLC
- $808 Million
- Q1 2024
A detailed history of Private Capital Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Private Capital Management, LLC holds 3,012,393 shares of HROW stock, worth $54.1 Million. This represents 4.93% of its overall portfolio holdings.
Number of Shares
3,012,393
Previous 2,794,497
7.8%
Holding current value
$54.1 Million
Previous $31.3 Million
27.33%
% of portfolio
4.93%
Previous 3.97%
Shares
8 transactions
Others Institutions Holding HROW
# of Institutions
123Shares Held
21.3MCall Options Held
113KPut Options Held
366K-
Opaleye Management Inc. Boston, MA3.92MShares$70.4 Million12.62% of portfolio
-
Black Rock Inc. New York, NY2.18MShares$39.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$32.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY953KShares$17.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA694KShares$12.5 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $486M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...